Article
Andexanet alfa-associated heparin resistance in cardiac surgery: mechanism and <i>in vitro</i> perspectives
2024-09-10
Abstract excerpt
<h4>Background</h4> Andexanet alfa (andexanet) is the only FDA-approved antidote for direct factor Xa (FXa) inhibitors but has been reported to cause resistance to unfractionated heparin (UFH). This has delayed anticoagulation for procedures requiring cardiopulmonary bypass (CPB). The mechanism, andexanet and UFH dose dependence, and thrombotic risk of andexanet-associated heparin resistance are unknown. <h4>Meth...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 403adbc6-9c26-5bae-97e1-725a5a90e3d5
- DOI
- 10.1101/2024.09.09.612152
